A novel ω-conotoxin Bu8 inhibiting N-type voltage-gated calcium channels displays potent analgesic activity
Publication date: Available online 18 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Jinqin Chen, Xinhong Liu, Shuo Yu, Jia Liu, Rongfang Chen, Yunxiao Zhang, Ling Jiang, Qiuyun Dai (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 18, 2021 Category: Cancer & Oncology Source Type: research
Cover Story
Publication date: March 2021Source: Acta Pharmaceutica Sinica B, Volume 11, Issue 3Author(s): (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 16, 2021 Category: Cancer & Oncology Source Type: research
Table of Contents
Publication date: March 2021Source: Acta Pharmaceutica Sinica B, Volume 11, Issue 3Author(s): (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 16, 2021 Category: Cancer & Oncology Source Type: research
Innate and adaptive immune responses toward nanomedicines
Publication date: Available online 13 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Iara Maíra de Oliveira Viana, Sabrina Roussel, Joan Defrêne, Eliana Martins Lima, Frédéric Barabé, Nicolas Bertrand (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 15, 2021 Category: Cancer & Oncology Source Type: research
Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis
Publication date: Available online 13 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Zhe Zhao, Fangyuan Li, Jingwen Ning, Ran Peng, Junmei Shang, Hui Liu, Meiyu Shang, Xiu-Qi Bao, Dan Zhang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 13, 2021 Category: Cancer & Oncology Source Type: research
Protocatechuic aldehyde protects cardiomycoytes against ischemic injury via regulation of nuclear pyruvate kinase M2
Publication date: Available online 13 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Xunxun Wu, Lian Liu, Qiuling Zheng, Haiping Hao, Hui Ye, Ping Li, Hua Yang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 13, 2021 Category: Cancer & Oncology Source Type: research
Metal-organic frameworks for advanced drug delivery
Publication date: Available online 13 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Siyu He, Li Wu, Xue Li, Hongyu Sun, Ting Xiong, Jie Liu, Chengxi Huang, Huipeng Xu, Huimin Sun, Weidong Chen, Ruxandra Gref, Jiwen Zhang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 13, 2021 Category: Cancer & Oncology Source Type: research
Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
Publication date: Available online 13 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Cláudia Pina Costa, João Nuno Moreira, José Manuel Sousa Lobo, Ana Catarina Silva (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 13, 2021 Category: Cancer & Oncology Source Type: research
Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease
Publication date: Available online 11 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Xiaojiaoyang Li, Junde Ge, Yajing Li, Yajie Cai, Qi Zheng, Nana Huang, Yiqing Gu, Qi Han, Yunqian Li, Rong Sun, Runping Liu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 12, 2021 Category: Cancer & Oncology Source Type: research
Cytosolic delivery of the immunological adjuvant Poly I:C and cytotoxic drug crystals via a carrier-free strategy significantly amplifies immune response
Publication date: Available online 12 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Xiaoqing Du, Yuqi Hou, Jia Huang, Yan Pang, Chenlu Ruan, Wei Wu, Chenjie Xu, Hongwei Zhang, Lifang Yin, Wei He (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 12, 2021 Category: Cancer & Oncology Source Type: research
Opportunities and challenges of three-dimensional printing technology in pharmaceutical formulation development
Publication date: Available online 12 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Mengsuo Cui, Hao Pan, Yupei Su, Dongyang Fang, Sen Qiao, Pingtian Ding, Weisan Pan (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 12, 2021 Category: Cancer & Oncology Source Type: research
Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies
Publication date: Available online 12 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Qin Wang, Xianyan Qin, Jiyu Fang, Xun Sun (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 12, 2021 Category: Cancer & Oncology Source Type: research
Recent advances in microneedles-mediated transdermal delivery of protein and peptide drugs
Publication date: Available online 10 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Ting Liu, Minglong Chen, Jintao Fu, Ying Sun, Chao Lu, Guilan Quan, Xin Pan, Chuanbin Wu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 12, 2021 Category: Cancer & Oncology Source Type: research
Gastrointestinal lipolysis and trans-epithelial transport of SMEDDS via oral route
Publication date: Available online 10 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Fei Xia, Zhongjian Chen, Quangang Zhu, Jianping Qi, Xiaochun Dong, Weili Zhao, Wei Wu, Yi Lu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 12, 2021 Category: Cancer & Oncology Source Type: research
Repurposing CFDA-approved drug carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2
Publication date: Available online 11 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Haiyan Yan, Jing Sun, Kun Wang, Huiqiang Wang, Shuo Wu, Linlin Bao, Weiqing He, Dong Wang, Airu Zhu, Tian Zhang, Rongmei Gao, Biao Dong, Jianrui Li, Lu Yang, Ming Zhong, Qi Lv, Feifei Qin, Zhen Zhuang, Xiaofang Huang, Xinyi Yang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 12, 2021 Category: Cancer & Oncology Source Type: research
